Michael T. Osterholm: the future of ADVOCACY on AMR
13 January 2021
In this first article, Dr Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and, most recently, a member of President-elect Joe Biden’s Transition COVID-19 Advisory Board, describes how we can all become advocates for a new and better future, in spite of the increasingly complex threat of antimicrobial resistance.
Further reading: BSAC
Author(s): Michael Osterholm
Effective Surveillance
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!